CARDIFF ONCOLOGY, INC. Research and Development Expense (Excluding Acquired in Process Cost)
CARDIFF ONCOLOGY, INC. (CRDF) reported Research and Development Expense (Excluding Acquired in Process Cost) of $5.92 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost · last filed 2026-08-11
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2026-06-30 was $5.92M, a 48.92% decline year-over-year.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2026-03-31 was $6.76M, a 35.43% decline year-over-year.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2025-12-31 was $5.08M, a 47.75% decline year-over-year.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for the quarter ending 2025-09-30 was $8.20M, a 14.97% decline year-over-year.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for fiscal 2025 was $35.33M, a 4.13% decline from fiscal 2024.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for fiscal 2024 was $36.85M, a 12.16% increase from fiscal 2023.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for fiscal 2023 was $32.86M, a 21.21% increase from fiscal 2022.
- CARDIFF ONCOLOGY, INC. research and development expense (excluding acquired in process cost) for fiscal 2022 was $27.11M, a 56.00% increase from fiscal 2021.
| Period end | Research and Development Expense (Excluding Acquired in Process Cost) 3 month | Research and Development Expense (Excluding Acquired in Process Cost) 3 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 6 month | Research and Development Expense (Excluding Acquired in Process Cost) 6 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 9 month | Research and Development Expense (Excluding Acquired in Process Cost) 9 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 12 month | Research and Development Expense (Excluding Acquired in Process Cost) 12 month as first filed | Research and Development Expense (Excluding Acquired in Process Cost) 152 month | Research and Development Expense (Excluding Acquired in Process Cost) 155 month | Research and Development Expense (Excluding Acquired in Process Cost) 158 month | Research and Development Expense (Excluding Acquired in Process Cost) 161 month | Research and Development Expense (Excluding Acquired in Process Cost) 164 month | Research and Development Expense (Excluding Acquired in Process Cost) 167 month | Research and Development Expense (Excluding Acquired in Process Cost) 170 month | Research and Development Expense (Excluding Acquired in Process Cost) 173 month | Research and Development Expense (Excluding Acquired in Process Cost) 176 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $5.92M 10-Q · filed 2026-08-11 | $12.68M 10-Q · filed 2026-08-11 | $17.75M derived: sum of 3 quarters · filed 2026-08-11 | $25.95M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2026-03-31 | $6.76M 10-Q · filed 2026-05-14 | $11.84M derived: sum of 2 quarters · filed 2026-05-14 | $20.04M derived: sum of 3 quarters · filed 2026-05-14 | $31.62M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-12-31 | $5.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $13.27M derived: sum of 2 quarters · filed 2026-02-24 | $24.85M derived: sum of 3 quarters · filed 2026-08-11 | $35.33M 10-K · filed 2026-02-24 | |||||||||||||
| 2025-09-30 | $8.20M 10-Q · filed 2025-11-06 | $19.78M derived: sum of 2 quarters · filed 2026-08-11 | $30.25M 10-Q · filed 2025-11-06 | $39.97M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-06-30 | $11.58M 10-Q · filed 2026-08-11 | $22.06M 10-Q · filed 2026-08-11 | $31.77M derived: sum of 3 quarters · filed 2026-08-11 | $41.41M derived: sum of 4 quarters · filed 2026-08-11 | |||||||||||||
| 2025-03-31 | $10.48M 10-Q · filed 2026-05-14 | $20.19M derived: sum of 2 quarters · filed 2026-05-14 | $29.83M derived: sum of 3 quarters · filed 2026-05-14 | $39.32M derived: sum of 4 quarters · filed 2026-05-14 | |||||||||||||
| 2024-12-31 | $9.71M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $19.35M derived: sum of 2 quarters · filed 2026-02-24 | $28.84M derived: sum of 3 quarters · filed 2026-02-24 | $36.85M 10-K · filed 2026-02-24 | |||||||||||||
| 2024-09-30 | $9.64M 10-Q · filed 2025-11-06 | $19.13M derived: sum of 2 quarters · filed 2025-11-06 | $27.14M 10-Q · filed 2025-11-06 | $34.90M derived: sum of 4 quarters · filed 2025-11-06 | |||||||||||||
| 2024-06-30 | $9.49M 10-Q · filed 2025-07-29 | $17.50M 10-Q · filed 2025-07-29 | $25.26M derived: sum of 3 quarters · filed 2025-07-29 | $33.29M derived: sum of 4 quarters · filed 2025-07-29 | |||||||||||||
| 2024-03-31 | $8.01M 10-Q · filed 2025-05-08 | $15.77M derived: sum of 2 quarters · filed 2025-05-08 | $23.79M derived: sum of 3 quarters · filed 2025-05-08 | $31.81M derived: sum of 4 quarters · filed 2025-05-08 | |||||||||||||
| 2023-12-31 | $7.76M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $15.79M derived: sum of 2 quarters · filed 2025-02-27 | $23.80M derived: sum of 3 quarters · filed 2025-02-27 | $32.86M 10-K · filed 2025-02-27 | |||||||||||||
| 2023-09-30 | $8.02M 10-Q · filed 2024-11-07 | $16.04M derived: sum of 2 quarters · filed 2024-11-07 | $25.09M 10-Q · filed 2024-11-07 | $31.54M derived: sum of 4 quarters · filed 2024-11-07 | |||||||||||||
| 2023-06-30 | $8.02M 10-Q · filed 2024-08-08 | $17.07M 10-Q · filed 2024-08-08 | $23.51M derived: sum of 3 quarters · filed 2024-08-08 | $29.52M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||||
| 2023-03-31 | $9.05M 10-Q · filed 2024-05-02 | $15.49M derived: sum of 2 quarters · filed 2024-05-02 | $21.50M derived: sum of 3 quarters · filed 2024-05-02 | $28.95M derived: sum of 4 quarters · filed 2024-05-02 | |||||||||||||
| 2022-12-31 | $6.44M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $12.45M derived: sum of 2 quarters · filed 2024-02-29 | $19.90M derived: sum of 3 quarters · filed 2024-02-29 | $27.11M 10-K · filed 2024-02-29 | |||||||||||||
| 2022-09-30 | $6.01M 10-Q · filed 2023-11-02 | $13.46M derived: sum of 2 quarters · filed 2023-11-02 | $20.66M 10-Q · filed 2023-11-02 | $26.49M derived: sum of 4 quarters · filed 2023-11-02 | |||||||||||||
| 2022-06-30 | $7.45M 10-Q · filed 2023-08-09 | $14.66M 10-Q · filed 2023-08-09 | $20.48M derived: sum of 3 quarters · filed 2023-08-09 | $24.63M derived: sum of 4 quarters · filed 2023-08-09 | |||||||||||||
| 2022-03-31 | $7.21M 10-Q · filed 2023-05-04 | $13.03M derived: sum of 2 quarters · filed 2023-05-04 | $17.19M derived: sum of 3 quarters · filed 2023-05-04 | $21.30M derived: sum of 4 quarters · filed 2023-05-04 | |||||||||||||
| 2021-12-31 | $5.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $9.98M derived: sum of 2 quarters · filed 2023-03-02 | $14.10M derived: sum of 3 quarters · filed 2023-03-02 | $17.38M 10-K · filed 2023-03-02 | |||||||||||||
| 2021-09-30 | $4.15M 10-Q · filed 2022-11-03 | $8.27M derived: sum of 2 quarters · filed 2022-11-03 | $11.55M 10-Q · filed 2022-11-03 | $14.75M derived: sum of 4 quarters · filed 2022-11-03 | |||||||||||||
| 2021-06-30 | $4.12M 10-Q · filed 2022-08-04 | $7.40M 10-Q · filed 2022-08-04 | $10.60M derived: sum of 3 quarters · filed 2022-08-04 | $13.45M derived: sum of 4 quarters · filed 2022-08-04 | |||||||||||||
| 2021-03-31 | $3.28M 10-Q · filed 2022-05-05 | $6.48M derived: sum of 2 quarters · filed 2022-05-05 | $9.33M derived: sum of 3 quarters · filed 2022-05-05 | $11.81M derived: sum of 4 quarters · filed 2022-05-05 | |||||||||||||
| 2020-12-31 | $3.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.05M derived: sum of 2 quarters · filed 2022-02-24 | $8.53M derived: sum of 3 quarters · filed 2022-02-24 | $11.23M 10-K · filed 2022-02-24 | $11.24M 10-K · filed 2021-02-25 | ||||||||||||
| 2020-09-30 | $2.85M 10-Q · filed 2021-11-04 | $2.85M 10-Q · filed 2020-11-05 | $5.33M derived: sum of 2 quarters · filed 2021-11-04 | $8.04M 10-Q · filed 2021-11-04 | $8.04M 10-Q · filed 2020-11-05 | $10.90M derived: sum of 4 quarters · filed 2021-11-04 | |||||||||||
| 2020-06-30 | $2.48M 10-Q · filed 2021-08-05 | $2.48M 10-Q · filed 2020-08-11 | $5.18M 10-Q · filed 2021-08-05 | $5.18M 10-Q · filed 2020-08-11 | $8.05M derived: sum of 3 quarters · filed 2021-08-05 | $10.87M derived: sum of 4 quarters · filed 2021-08-05 | |||||||||||
| 2020-03-31 | $2.71M 10-Q · filed 2021-05-06 | $2.71M 10-Q · filed 2020-05-07 | $5.57M derived: sum of 2 quarters · filed 2021-05-06 | $8.39M derived: sum of 3 quarters · filed 2021-05-06 | $11.22M derived: sum of 4 quarters · filed 2021-05-06 | ||||||||||||
| 2019-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $5.68M derived: sum of 2 quarters · filed 2021-02-25 | $8.51M derived: sum of 3 quarters · filed 2021-02-25 | $11.16M 10-K · filed 2021-02-25 | |||||||||||||
| 2019-09-30 | $2.82M 10-Q · filed 2020-11-05 | $5.65M derived: sum of 2 quarters · filed 2020-11-05 | $8.30M 10-Q · filed 2020-11-05 | $10.79M derived: sum of 4 quarters · filed 2020-11-05 | |||||||||||||
| 2019-06-30 | $2.83M 10-Q · filed 2020-08-11 | $5.48M 10-Q · filed 2020-08-11 | $7.98M derived: sum of 3 quarters · filed 2020-08-11 | $9.81M derived: sum of 4 quarters · filed 2020-08-11 | |||||||||||||
| 2019-03-31 | $2.65M 10-Q · filed 2020-05-07 | $5.15M derived: sum of 2 quarters · filed 2020-05-07 | $6.98M derived: sum of 3 quarters · filed 2020-05-07 | $8.93M derived: sum of 4 quarters · filed 2020-05-07 | |||||||||||||
| 2018-12-31 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.33M derived: sum of 2 quarters · filed 2020-02-27 | $6.28M derived: sum of 3 quarters · filed 2020-02-27 | $8.16M 10-K · filed 2020-02-27 | |||||||||||||
| 2018-09-30 | $1.83M 10-Q · filed 2019-11-07 | $3.78M derived: sum of 2 quarters · filed 2019-11-07 | $5.67M 10-Q · filed 2019-11-07 | $6.87M derived: sum of 4 quarters · filed 2019-11-07 | |||||||||||||
| 2018-06-30 | $1.95M 10-Q · filed 2019-08-08 | $3.84M 10-Q · filed 2019-08-08 | $5.04M derived: sum of 3 quarters · filed 2019-08-08 | $6.46M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||||
| 2018-03-31 | $1.88M 10-Q · filed 2019-05-07 | $3.09M derived: sum of 2 quarters · filed 2019-05-07 | $4.50M derived: sum of 3 quarters · filed 2019-05-07 | $5.49M derived: sum of 4 quarters · filed 2019-05-07 | |||||||||||||
| 2017-12-31 | $1.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-06 | $2.62M derived: sum of 2 quarters · filed 2019-03-06 | $3.60M derived: sum of 3 quarters · filed 2019-03-06 | $7.88M 10-K · filed 2019-03-06 | |||||||||||||
| 2017-09-30 | $1.41M 10-Q · filed 2018-11-07 | $2.40M derived: sum of 2 quarters · filed 2018-11-07 | $6.68M 10-Q · filed 2018-11-07 | $10.46M derived: sum of 4 quarters · filed 2018-11-07 | |||||||||||||
| 2017-06-30 | $981.72K 10-Q · filed 2018-08-03 | $5.26M 10-Q · filed 2018-08-03 | $9.05M derived: sum of 3 quarters · filed 2018-08-03 | $12.98M derived: sum of 4 quarters · filed 2018-08-03 | |||||||||||||
| 2017-03-31 | $4.28M 10-Q · filed 2018-05-08 | $8.06M derived: sum of 2 quarters · filed 2018-05-08 | $12.00M derived: sum of 3 quarters · filed 2018-05-08 | $16.08M derived: sum of 4 quarters · filed 2018-05-08 | |||||||||||||
| 2016-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.72M derived: sum of 2 quarters · filed 2018-02-26 | $11.80M derived: sum of 3 quarters · filed 2018-02-26 | $15.01M 10-K · filed 2018-02-26 | |||||||||||||
| 2016-09-30 | $3.94M 10-Q · filed 2017-11-09 | $8.01M derived: sum of 2 quarters · filed 2017-11-09 | $11.22M 10-Q · filed 2017-11-09 | $14.39M derived: sum of 4 quarters · filed 2017-11-09 | |||||||||||||
| 2016-06-30 | $4.08M 10-Q · filed 2017-08-09 | $7.28M 10-Q · filed 2017-08-09 | $10.45M derived: sum of 3 quarters · filed 2017-08-09 | $13.00M derived: sum of 4 quarters · filed 2017-08-09 | |||||||||||||
| 2016-03-31 | $3.21M 10-Q · filed 2017-05-10 | $6.37M derived: sum of 2 quarters · filed 2017-05-10 | $8.92M derived: sum of 3 quarters · filed 2017-05-10 | $11.60M derived: sum of 4 quarters · filed 2017-05-10 | |||||||||||||
| 2015-12-31 | $3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $5.71M derived: sum of 2 quarters · filed 2017-03-15 | $8.40M derived: sum of 3 quarters · filed 2017-03-15 | $10.59M 10-K · filed 2017-03-15 | |||||||||||||
| 2015-09-30 | $2.55M 10-Q · filed 2016-11-09 | $5.23M derived: sum of 2 quarters · filed 2016-11-09 | $7.43M 10-Q · filed 2016-11-09 | $9.26M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-06-30 | $2.68M 10-Q · filed 2016-08-04 | $4.88M 10-Q · filed 2016-08-04 | $6.72M derived: sum of 3 quarters · filed 2017-03-15 | $8.71M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2015-03-31 | $2.20M 10-Q · filed 2016-05-10 | $4.03M derived: sum of 2 quarters · filed 2017-03-15 | $6.02M derived: sum of 3 quarters · filed 2017-03-15 | $7.42M derived: sum of 4 quarters · filed 2017-03-15 | |||||||||||||
| 2014-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $3.83M derived: sum of 2 quarters · filed 2017-03-15 | $5.22M derived: sum of 3 quarters · filed 2017-03-15 | $6.66M 10-K · filed 2017-03-15 | |||||||||||||
| 2014-09-30 | $1.99M 10-Q · filed 2015-11-09 | $3.39M derived: sum of 2 quarters · filed 2015-11-09 | $4.83M 10-Q · filed 2015-11-09 | $6.12M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||
| 2014-06-30 | $1.40M 10-Q · filed 2015-08-10 | $2.84M 10-Q · filed 2015-08-10 | $4.13M derived: sum of 3 quarters · filed 2016-03-10 | $5.04M derived: sum of 4 quarters · filed 2016-03-10 | |||||||||||||
| 2014-03-31 | $1.44M 10-Q · filed 2015-05-05 | $2.73M derived: sum of 2 quarters · filed 2016-03-10 | $3.64M derived: sum of 3 quarters · filed 2016-03-10 | $4.59M derived: sum of 4 quarters · filed 2016-03-10 | $22.84M 10-Q · filed 2014-05-12 | ||||||||||||
| 2013-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $2.20M derived: sum of 2 quarters · filed 2016-03-10 | $3.15M derived: sum of 3 quarters · filed 2016-03-10 | $3.95M 10-K · filed 2016-03-10 | $21.40M 10-K · filed 2014-03-17 | ||||||||||||
| 2013-09-30 | $915.46K 10-Q · filed 2014-11-06 | $1.86M derived: sum of 2 quarters · filed 2014-11-06 | $2.66M 10-Q · filed 2014-11-06 | $2.66M 10-Q · filed 2013-11-14 | $3.26M derived: sum of 4 quarters · filed 2015-03-12 | $20.11M 10-Q · filed 2013-11-14 | |||||||||||
| 2013-06-30 | $943.85K 10-Q · filed 2014-08-07 | $1.75M 10-Q · filed 2014-08-07 | $2.34M derived: sum of 3 quarters · filed 2015-03-12 | $2.85M derived: sum of 4 quarters · filed 2015-03-12 | $19.20M 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $802.25K 10-Q · filed 2014-05-12 | $1.40M derived: sum of 2 quarters · filed 2015-03-12 | $1.91M derived: sum of 3 quarters · filed 2015-03-12 | $2.38M derived: sum of 4 quarters · filed 2015-03-12 | $18.25M 10-Q · filed 2013-05-14 | ||||||||||||
| 2012-12-31 | $594.10K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $1.11M derived: sum of 2 quarters · filed 2015-03-12 | $1.58M derived: sum of 3 quarters · filed 2015-03-12 | $1.92M 10-K · filed 2015-03-12 | $17.45M 10-K · filed 2013-04-01 | ||||||||||||
| 2012-09-30 | $511.43K 10-Q · filed 2013-11-14 | $988.58K derived: sum of 2 quarters · filed 2013-11-14 | $1.33M 10-Q · filed 2013-11-14 | $1.63M derived: sum of 4 quarters · filed 2014-03-17 | $16.86M 10-Q · filed 2012-11-14 | ||||||||||||
| 2012-06-30 | $477.15K 10-Q · filed 2013-08-14 | $814.56K 10-Q · filed 2013-08-14 | $1.12M derived: sum of 3 quarters · filed 2014-03-17 | $1.32M derived: sum of 4 quarters · filed 2014-03-17 | $16.34M 10-Q · filed 2012-08-14 | ||||||||||||
| 2012-03-31 | $337.41K 10-Q · filed 2013-05-14 | $645.86K derived: sum of 2 quarters · filed 2014-03-17 | $846.79K derived: sum of 3 quarters · filed 2014-03-17 | $990.08K derived: sum of 4 quarters · filed 2014-03-17 | $15.87M 10-Q · filed 2012-05-15 | ||||||||||||
| 2011-12-31 | $308.46K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $509.38K derived: sum of 2 quarters · filed 2014-03-17 | $652.67K derived: sum of 3 quarters · filed 2014-03-17 | $910.68K 10-K · filed 2014-03-17 | |||||||||||||
| 2011-09-30 | $200.92K 10-Q · filed 2012-11-14 | $344.21K derived: sum of 2 quarters · filed 2012-11-14 | $602.23K 10-Q · filed 2012-11-14 | ||||||||||||||
| 2011-06-30 | $143.29K 10-Q · filed 2012-08-14 | $401.30K 10-Q · filed 2012-08-14 | |||||||||||||||
| 2011-03-31 | $258.02K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B |